Related Experiment Video
Updated: May 16, 2026

07:14
A Culture Method to Maintain Quiescent Human Hematopoietic Stem Cells
Published on: May 17, 2021
Human long-term culture initiating cell assay
Min Liu1, Cindy L Miller, Connie J Eaves
1Terry Fox Laboratory, Vancouver, BC, Canada.
Methods in Molecular Biology (Clifton, N.J.)
|November 27, 2012
Summary
The long-term culture initiating cell (LTC-IC) assay quantifies primitive hematopoietic stem cells by assessing their ability to generate myeloid cells over five weeks. This method is adaptable for various human hematopoietic tissues, aiding stem cell research.
Area of Science:
- Hematology
- Stem Cell Biology
- Cell Culture
Background:
- The long-term culture initiating cell (LTC-IC) assay is crucial for measuring primitive hematopoietic stem cells.
- It is based on the established bone marrow long-term culture (LTC) system.
- LTC-IC are defined by their capacity to produce myeloid progeny for at least 5 weeks.
Purpose of the Study:
- To describe methodologies for measuring human LTC-IC.
- To detail adaptations of the LTC system for accurate LTC-IC quantification.
- To enable LTC-IC content determination in diverse human hematopoietic cell populations.
Main Methods:
- Utilizing the bone marrow long-term culture (LTC) system.
- Employing adaptations such as stromal cell lines and limiting dilution analysis.
- Describing methods for bulk cultures, limiting dilution analysis, and single cell cultures.
Main Results:
- Accurate determination of LTC-IC content is achievable in various human hematopoietic tissues.
- The assay can be applied to minimally separated and highly purified cell populations.
- The output of hematopoietic progenitors per LTC-IC can be estimated under defined conditions.
Conclusions:
- The LTC-IC assay is a robust method for quantifying primitive hematopoietic stem cells.
- Adaptations enhance the assay's applicability across different human hematopoietic sources.
- Standardized methodologies facilitate reliable LTC-IC measurement in research and clinical settings.
